We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$988M
AUM Growth
-$950M
(-49%)
Cap. Flow
-$941M
Cap. Flow
% of AUM
-95.22%
Top 10 Holdings %
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanterix
QTRX
|
+$23.5M |
| 2 |
Outset Medical
OM
|
+$11.4M |
| 3 |
LivaNova
LIVN
|
+$8.76M |
| 4 |
CUTR
Cutera, Inc.
CUTR
|
+$5.89M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$4.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$26.8M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$25.3M |
| 3 |
Biogen
BIIB
|
+$17.4M |
| 4 |
Establishment Labs
ESTA
|
+$15.9M |
| 5 |
VRAY
ViewRay, Inc.
VRAY
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.61% |
| 2 | Industrials | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Apyx Medical
APYX
$126M
| $4.24M | 0.43% |
1,471,258
+863,698
| +142% | +$2.52M |
|
52
SOPHiA GENETICS
SOPH
$635M
| $4.22M | 0.43% |
848,270
+94,234
| +12% | +$305K |
|
53
Transmedics
TMDX
$3.02B
| $4.17M | 0.42% |
55,000
-35,000
| -39% | -$2.42M |
|
|
LYRA
54
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $4.01M | 0.41% |
39,939
-3,207
| -7% | -$397K |
|
55
TELA Bio
TELA
$32.3M
| $3.96M | 0.4% |
371,809
-148,270
| -29% | -$1.64M |
|
56
CALL
Lantheus
LNTH
$6.57B
| $3.86M | 0.39% |
+46,800
| New | +$3.02M |
|
57
Bio-Techne
TECH
$11.3B
| $2.89M | 0.29% |
39,000
-29,000
| -43% | -$2.24M |
|
58
Repligen
RGEN
$9.35B
| $2.56M | 0.26% |
+15,200
| New | +$2.71M |
|
59
AtriCure
ATRC
$2.22B
| $2.33M | 0.24% |
+56,219
| New | +$2.33M |
|
60
PUT
Trupanion
TRUP
$1.33B
| $2.25M | 0.23% |
52,500
-22,500
| -30% | -$1.22M |
|
|
61
CALL
LivaNova
LIVN
$4.45B
| $2.18M | 0.22% |
50,000
-251,000
| -83% | -$12.7M |
|
|
AXNX
62
CALL
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.64M | 0.17% |
+30,000
| New | +$1.75M |
|
63
PUT
Twist Bioscience
TWST
$7.85B
| $1.51M | 0.15% |
100,000
| – | – |
|
|
SLGC
64
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.49M | 0.15% |
+585,202
| New | +$1.68M |
|
65
Solid Biosciences
SLDB
$971M
| $1.07M | 0.11% |
+224,902
| New | +$1.35M |
|
|
NYXH
66
Nyxoah
NYXH
$158M
| $978K | 0.1% |
131,129
-18,002
| -12% | -$101K |
|
|
ICAD
67
DELISTED
iCAD Inc
ICAD
| $475K | 0.05% |
383,102
-725,567
| -65% | -$1.51M |
|
68
GH Research
GHRS
$2.08B
| $200K | 0.02% |
25,000
-133,327
| -84% | -$1.23M |
|
|
MDVL
69
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $95.1K | 0.01% |
6,635
| – | – |
|
|
SLGCW
70
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $43.9K | ﹤0.01% |
173,876
-30,525
| -15% | -$13.4K |
|
|
TALKW
71
DELISTED
Talkspace Inc Warrant
TALKW
| $33.3K | ﹤0.01% |
378,000
-49,194
| -12% | -$5.62K |
|
72
Scilex Holding Co Warrant
SCLXW
$2.3M
| $13.3K | ﹤0.01% |
+12,699
| New | +$15.1K |
|
|
MAPSW
73
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
| $3.62K | ﹤0.01% |
50,000
| – | – |
|
|
SBIGW
74
DELISTED
SpringBig Holdings, Inc. Warrant
SBIGW
| $307 | ﹤0.01% |
10,000
| – | – |
|
75
ADMA Biologics
ADMA
$2.19B
| – | – |
-300,000
| Closed | -$1.16M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.
Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.
- Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
- Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
- Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
- Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
- Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
- Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
- Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.
Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.